MOG antibody disease is felt to be distinct from MS, however as there is not yet a biomarker for MS, we are bound by clinical diagnostic criteria (McDonald criteria) which are limited in their sensitivity and specificity. This evidence concerns the gene MOG and myeloid sarcoma.